Barclays PLC Supernus Pharmaceuticals, Inc. Put Options Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$29.96 - $38.87 $71,904 - $93,288
-2,400 Reduced 47.06%
2,700 $89,000
Q1 2019

May 15, 2019
BUY
$32.77 - $41.99 $88,479 - $113,373
2,700 Added 112.5%
5,100 $179,000
Q4 2018

Feb 14, 2019
BUY
$30.84 - $49.51 $67,848 - $108,922
2,200 Added 1100.0%
2,400 $80,000
Q3 2017

Nov 14, 2017
BUY
$36.75 - $49.65 $7,350 - $9,930
200
200 $8,000

Others Institutions Holding SUPN

# of Institutions
282
Shares Held
60.9M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.93B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email